Articles

Biopharmaceuticals at the forefront of knowledge

At the IV All-Russian Science Festival, the organizers of the competition of scientific papers in the field of chemistry, biology and pharmacy "Vanguard of Knowledge" awarded the authors of the best scientific papers in the field of cardiology and oncology.

How to check "pills for old age": age–related diseases - a marker of aging

How to evaluate the effectiveness of aging-slowing drugs without conducting life-long clinical trials involving healthy people?

Beta cells for diabetes treatment were taken out of the nose

Any of the two types of diabetes can be defeated by literally digging into the nose.

Organ transplantation: immunotherapy instead of immunosuppression

The new technique "trains" the recipient's immune system to accept donor cells for its own and allows you to do without taking immunosuppressants after organ transplantation.

Nanotechnology in healthcare and pharmaceuticals

The program of the section "Nanotechnology in healthcare and pharmaceuticals" of the IV International Forum "Rosnanotech 2011".

Somatic cell nucleus transfer: a new round of developments?

Embryonic stem cells with a triple set of chromosomes: hocus pocus or a promising direction?

Touch for virtual limbs

In the near future, people with limb paralysis will be able not only to move their arms and legs with the help of such technologies, but also to feel the shape and structure of things that they will touch and on which they will step.

Pros and cons of monoclonal antibody therapy

According to the authors of the article, monoclonal antibody therapy, despite its commercial attractiveness, is not a promising direction for long-term treatment.

Commercializing nanotechnology

The total budget of the nanotechnology commercialization center is 200 million rubles. Rusnano and the government of St. Petersburg will invest this project in equal shares.

What is happening in the pharmaceutical market: results of the III session

On September 26-27, 2011, the 3rd autumn session of the leaders of the pharmaceutical business "What is happening in the pharmaceutical market" took place?

II World Congress on Pharmaceuticals and Drug Delivery Systems

OMICS Publishing Group invites you to take part in the II World Congress on Pharmaceuticals and New Drug Delivery Systems (February 20-22, 2012, San Francisco, USA).

RFBR and NIH grants to study HIV infection

A joint competition of the RFBR and the US National Institutes of Health (NIH) to receive financial support for conducting basic scientific research in the field of HIV infection prevention.

Fulbright Scholarships for Russian Researchers

The Fulbright Program invites young Russian scientists to participate in a competition for a trip to one of the leading universities in the United States in order to conduct joint research during the 2012-13 academic year

Smart millionaires

Of the 187 young scientists who presented their innovative projects at the II All-Russian competition "Smart Guy at the Start", 60 people became finalists, each of whom received a diploma and 1 million rubles for the development of their own business.

RFBR and EMBL Grants: 2012 competition

The RFBR and the European Laboratory for Molecular Biology (EMBL) announce a 2012 competition to receive financial support for fundamental scientific research in the field of molecular biology.

Shnobelevka-2011

The ceremony of awarding the Shnobel (in another way - Antinobel or Ignobel, from the English word "Ignoble" – shameful) prize of this year at Harvard was held according to all the rules.

References to the article “Growth and aging: a common molecular mechanism”

Growth and aging: a common molecular mechanism. Part 3

Aging is a senseless continuation of the process of growth and development. A random mutation would not be able to disable the "growth-aging" program: it would be lethal or, at least, would reduce physical endurance during the development of the organism. However, the activity of TOR can be inhibited by pharmacological methods.

Growth and aging: a common molecular mechanism. Part 2

Despite the fact that the mechanisms by which a low-calorie diet slows down aging are still being discussed, one of them, with a high degree of probability, is the inactivation of the TOR-mediated signaling mechanism.

Growth and aging: a common molecular mechanism. Part 1

The signaling mechanism mediated by the TOR protein may well be a molecular "bridge" between the processes of growth and aging, universal for a huge number of organisms, ranging from yeast to humans.